Role of HTLV-I infection in the pathogenesis of Sjögren's syndrome and rheumatoid arthritis

References

• Poiesz BJ, Ruscetti FW, Gazdar AF, Bunn PA, Minna JD, Gallo RC. Detection and isolation of type C retrovirus particles from fresh and cultured lymphocytes of a patient with cutaneous T-cell lymphoma. Proc Natl Acad Sci USA 1980;77:7415–9.
   PubMed Web of Science ®Google Scholar
• Hinuma Y, Nagata K, Hanaoka M, Nakai M, Matsumoto T, Kinoshita KI, et al. Adult T-cell leukemia: antigen in an ATL cell line and detection of antibodies to the antigen in human sera. Proc Natl Acad Sci USA 1981;78:6476–80.
   PubMed Web of Science ®Google Scholar
• Gessain A, Barin F, Vernant JC, Gout O, Maurs L, Calender A, et al. Antibodies to human T-lymphotropic virus type-I in patients with tropical spastic paraparesis. Lancet 1985;8452:407–10.
   Google Scholar
• Osame M, Usuku K, Izumo S, Ijichi N, Amitani H, Igata A, et al. HTLV-I associated myelopathy: a new clinical entity. Lancet 1986;8488:1031–2.
   Google Scholar
• Eguchi K, Matsuoka N, Ida H, Nakashima M, Sakai M, Sakito S, et al. Primary Sjögren's syndrome with antibodies to HTLV-I: clinical and laboratory features. Ann Rheum Dis 1992;51:769–76.
   PubMed Web of Science ®Google Scholar
• Terada K, Katamine S, Eguchi K, Moriuchi R, Kita M, Shimada H, et al. Prevalence of serum and salivary antibodies to HTLV-I in Sjögren's syndrome. Lancet 1994;344:1116–9.
   PubMed Web of Science ®Google Scholar
• Eguchi K, Origuchi T, Takashima H, Iwata K, Katamine S, Nagataki S. High seroprevalence of anti-HTLV-I antibody in rheu-matoid arthritis. Arthritis Rheum 1996;39:463–6.
   PubMed Web of Science ®Google Scholar
• Nakamura H, Eguchi K, Nakamura T, Mizokami A, Shirabe S, Kawakami A, et al. High prevalence of Sj8gren's syndrome in patients with HTLV-I-associated myelopathy. Ann Rheum Dis 1997;56:167–72.
   PubMed Web of Science ®Google Scholar
• Nakamura H, Kawakami A, Tominaga M, Hida A, Yamasaki S, Migita K, et al. Relationship between Sjögren's syndrome and human T-lymphotropic virus type I infection: follow-up study of 83 patients. J Lab Clin Med 2000;135:139–44.
   PubMed Web of Science ®Google Scholar
• Ichinose K, Nakamura T, Kawakami A, Eguchi K, Nagasato K, Shibayama K, et al. Increased adherence of T cells to human endothelial cells in patients with human T-cell lymphotropic virus type I-associated myelopathy. Arch Neurol 1992;49:74–6.
   PubMed Web of Science ®Google Scholar
• Furuya T, Nakamura T, Shirabe S, Nishiura Y, Tsujino A, Goto H, et al. Heightened transmigrating activity of CD4-positive T cells through reconstituted basement membrane in patients with human T-lymphotropic virus type I-associated myelopathy. Proc Assoc Am Physicians 1997;109:228–36.
   Google Scholar
• Kitajima I, Yamamoto K, Sato K, Nakajima Y, Nakajima T, Maruyama I, et al. Detection of human T cell lymphotropic virus type I proviral DNA and its gene expression in synovial cells in chronic inflammatory arthropathy. J Clin Invest 1991;88:1315–22.
   PubMed Web of Science ®Google Scholar
• Wano Y, Hattori T, Matsuoka M, Takatsuki K, Chua AO, Gunter U, et al. Interleukin 1 gene expression in adult T cell leukemia. J Chin Invest 1987;80:911–6.
   PubMed Web of Science ®Google Scholar
• Maruyama M, Shibuya H, Harada H, Hatakeyama M, Seiki M, Fujita T, et al. Evidence for aberrant activation of the interleukin-2 autocrine loop by HTLV-I-encoded p4Ox and T3/Ti complex triggering. Cell 1987;48:343–50.
   PubMed Web of Science ®Google Scholar
• Siekevitz M, Feinberg MB, Holbrook N, Wong-Staal F, Greene WC. Activation of interleukin-2 and interleukin-2 receptor (Tac) promotor expression by the transactivator (tat) gene product of human T-cell leukemia virus type I. Proc Natl Acad Sci USA 1987;84: 5389–93.
   Google Scholar
• Sakai M, Eguchi K, Terada K, Nakashima M, Yamashita I, Ida H, et al. Infection of human synovial cells by human T cell lymphotropic virus type I. Proliferation and granulocyte/macroph-age colony-stimulating factor production by synovial cells. J Clin Invest 1993;92:1957–66.
   Google Scholar
• Takashima H, Eguchi K, Kawakami A, Kawabe Y, Migita K, Sakai M, et al. Cytokine production by endothelial cells infected with human T cell lymphotropic virus type I. Ann Rheum Dis 1996;55: 632–7.
   Google Scholar
• Baeuerle PA, Henkel T. Function and activation of NF-KB in the immune system. Annu Rev Immunol 1994;12:141–79.
   PubMed Web of Science ®Google Scholar
• Yamashita I, Katamine S, Moriuchi R, Nakamura Y, Miyamoto T, Eguchi K, et al. Transactivation of the human interleukin-6 gene by human T-lymphotropic virus type 1 Tax protein. Blood 1994;84: 1573–8.
   PubMed Web of Science ®Google Scholar
• Wang C-Y, Mayo MW, Balwin Jr AS. TNF- and cancer therapy-induced apoptosis: potentiation by inhibition of NF-x13. Science 1996;274: 784–7.
   Google Scholar
• Van Antwerp DJ, Martin SJ, Kafri T, Green DR, Verma IM. Suppression of TNF-a-induced apoptosis by NF-x13. Science 1996; 274:787–9.
   Google Scholar
• Liu Z-G, Hsu H, Goeddel D, Karin M. Dissection of TNF re-ceptor 1 effector function: JNK activation is not linked to apoptosis while NF-x13 activation prevents cell death. Cell 1996;87: 565–76.
   Google Scholar
• Nagata S. Apoptosis by death factor. Cell 1997;88:355–65.
   PubMed Web of Science ®Google Scholar
• Deveraux QL, Takahashi R, Salvesen GS, Reed JC. X-linked IAP is a direct inhibitor of cell death proteases. Nature 1997;388:300–3.
   PubMed Web of Science ®Google Scholar
• Deveraux QL, Roy N, Stennicke HR, Van Arsdale T, Zhou Q, Srinivasula SM, et al. IAPs block apoptotic events induced by caspase-8 and cytochrome c by direct inhibition of distinct caspases. EMBO J 1998;17: 2215–23.
   Google Scholar
• Chao DT, Korsmeyer SJ. BCL-2 family: regulators of cell death. Annu Rev Immunol 1998;16:395–419.
   PubMed Web of Science ®Google Scholar
• Kawakami A, Nakashima T, Sakai H, Urayama S, Yamasaki S, Hida A, et al. Inhibition of caspase cascade by HTLV-I Tax through induction of NF-KB nuclear translocation. Blood 1999;94: 3847–54.
   PubMed Web of Science ®Google Scholar
• Wang C-Y, Mayo MW, Korneluk RG, Goeddel DV, Baldwin Jr AS. NF-x13 antiapoptosis: induction of TFtAF1 and TFtAF2 and c-IAP1 and c-IAP2 to suppress caspase-8 activation. Science 1998; 281:1680–3.
   Google Scholar
• Stehlik C, Martin R, Kumabashiri I, Schmid JA, Binder BR, Lipp J. Nuclear factor (NF)-KB-regulated X-chromosome-linked iap gene expression protects endothelial cells from tumor necrosis factor a-induced apoptosis. J Exp Med 1998;188:211–6.
   PubMed Web of Science ®Google Scholar
• Tsukahara T, Kannagi M, Ohashi T, Kato H, Arai M, Nunez G, et al. Induction of Bc1-x(L) expression by human T-cell leukemia virus type 1 Tax through NF-KB in apoptosis-resistant T-cell transfectants with Tax. J Virol 1999;73:7981–7.
   PubMed Web of Science ®Google Scholar
• Kishi S, Saijyo S, Arai K, Karasawa S, Ueda S, Kannnagi M, et al. Resistance to fas-mediated apoptosis of peripheral T cells in hu-man T lymphocyte virus type I (HTLV-I) transgenic mice with autoimmune arthropathy. J Exp Med 1997;186:57–64.
   PubMed Web of Science ®Google Scholar
• Pise-Masison CA, Mahieux R, Jiang H, Ashcroft M, Radonovich M, Duvall J, et al. Inactivation of p53 by human T-cell lympho-tropic virus type 1 Tax requires activation of the NF-KB pathway and is dependent on p53 phosphorylation. Mol Cell Biol 2000;20: 3377–86.
   Google Scholar
• Takei M, Mitamura K, Fujiwara S, Hone T, Ryu J, Osaka S, et al. Detection of Epstein-Barr virus-encoded small RNA 1 and latent membrane protein 1 in synovial lining cells from rheumatoid ar-thritis patients. Int Immunol 1997;9:739–43.
   PubMed Web of Science ®Google Scholar
• Fox RI, Pearson G, Vaughan JH. Detection of Epstein-Barr virus-associated antigens and DNA in salivary gland biopsies from patients with Sjögren's syndrome. J Immunol 1986;137:3162–8.
   Google Scholar
• Saito I, Servenius B, Compton T, Fox RI. Detection of Epstein-Barr virus DNA by polymerase chain reaction in blood and tissue biopsies from patients with Sjögren's syndrome. J Exp Med 1989; 169:2191–8.
   PubMed Web of Science ®Google Scholar
• Takahashi Y, Murai C, Shibata S, Munakata Y, Ishii T, Ishii K, et al. Human parvovirus B19 as a causative agent for rheumatoid arthritis. Proc Natl Acad Sci USA 1998;95:8227–32.
   PubMed Web of Science ®Google Scholar
• Henderson S, Rowe M, Gregory C, Croom-Carter D, Wang F, Longnecker R, et al. Induction of bc1-2 expression by Epstein-Barr virus latent membrane protein 1 protects infected B cells from programmed cell death. Cell 1991;65: 1107–15.
   Google Scholar
• Hammarskjold ML, Simurda MC. Epstein-Barr virus latent mem-brane protein transactivates the human immunodeficiency virus type 1 long terminal repeat through induction of NF-KB activity. J Virol 1992;66:6496–501.
   PubMed Web of Science ®Google Scholar
• Henderson S, Huen D, Rowe M, Dawson C, Johnson G, Ftickinson A. Epstein-Barr virus-coded BHFtF1 protein, a viral homologue of Bc1-2, protects human B cells from programmed cell death. Proc Natl Acad Sci USA 1993;90:8479–83.
   PubMed Web of Science ®Google Scholar
• Moffatt S, Tanaka N, Tada K, Nose M, Nakamura M, Muraoka O, et al. A cytotoxic nonstructural protein, NS1, of human parvovirus B19 induces activation of interleukin-6 gene expression. J Virol 1996;70:8485–91.
   PubMed Web of Science ®Google Scholar
• Nakamura H, Koji T, Tominaga M, Kawakami A, Migita K, Kawabe Y, et al. Apoptosis in labial salivary glands from Sj8gren's syndrome patients. Comparison with HTLV-I-seronegative and -seropositive Sjögren's syndrome patients. Clin Exp Immunol 1998;114:106–12.
   Google Scholar
• Nakamura H, Kawakami A, Tominaga M, Migita K, Kawabe Y, Nakamura T, et al. Expression of CD40/CD40 ligand and Bc1-2 family proteins in labial salivary glands of patients with Sjögren's syndrome. Lab Invest 1999;79:261–9.
   PubMed Web of Science ®Google Scholar
• Nakamura H, Kawakami A, Yamasaki S, Kawabe Y, Nakamura T, Eguchi K. Expression of mitogen-activated protein kinases in labial salivary glands of patients with Sjögren's syndrome. Ann Rheum Dis 1999;58:382–5.
   PubMedGoogle Scholar
• Nakamura H, Kawakami A, Yamasaki S, Nakashima T, Kamachi M, Migita K, et al. Expression and function of X-chromosome-linked inhibitor of apoptosis protein in Sjögren's syndrome. Lab Invest 2000;80:1421–7.
   Google Scholar
• Saal JG, Krimmel M, Steidle M, Gerneth F, Wagner S, Fritz P, et al. Synovial Epstein-Barr virus infection increases the risk of rheu-matoid arthritis in individuals with the shared HLA-DR4 epitope. Arthritis Rheum 1999;42:1485–96.
   PubMed Web of Science ®Google Scholar